4Filed Sep 14, 8:00 PM ET
Credo (CRDO) CTO Cheng Chi Fung Sells 27,500 Shares
$CRDO · Credo Technology Group Holding LtdResearch Summary
AI-generated summary of this SEC filing
Credo (CRDO) CTO Cheng Chi Fung Sells 27,500 Shares
What Happened
- Cheng Chi Fung, Credo Technology Group Holding Ltd's Chief Technology Officer and a director, sold a total of 27,500 ordinary shares in open-market transactions on September 11, 2026, for aggregate proceeds of about $4,475,185. The sales were reported as four tranches:
- 600 shares at a weighted average price of $160.99 — proceeds $96,593 (trades ranged $160.60–$161.36)
- 12,912 shares at $162.18 — proceeds $2,094,124 (trades ranged $161.62–$162.61)
- 9,585 shares at $163.06 — proceeds $1,562,906 (trades ranged $162.62–$163.61)
- 4,403 shares at $163.88 — proceeds $721,562 (trades ranged $163.62–$164.52)
- These transactions are sales (code S) — routine insider selling rather than a purchase signal.
Key Details
- Transaction date: September 11, 2026; Form 4 filed September 15, 2026 (filed within the two-business-day window).
- Total shares sold: 27,500 for total proceeds of approximately $4.48 million.
- Price details: reported as weighted averages; each tranche was executed in multiple trades (see ranges above). The reporting person has offered to provide full per-trade details on request (per filing).
- 10b5-1 plan: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on September 5, 2025.
- Trust holdings: The shares sold are reported as held by the Cheng Huang Family Trust (the reporting person and spouse are trustees; they disclaim beneficial ownership except for pecuniary interest). See Form 4 for post-transaction holdings — the summary provided here does not state shares owned after the sales.
Context
- Sales executed under a 10b5-1 plan are prearranged and commonly used to avoid questions about trading on inside information; they do not necessarily reflect current management sentiment.
- For retail investors, purchases typically carry more direct informational weight than scheduled sales. For full verification or per-trade pricing details, consult the Form 4 filing (Accession No. 0001628280-26-062039).